DrugDashboards

Ropivacaine Hydrochloride

Ropivacaine Hydrochloride · ROPIVACAINE HYDROCHLORIDE 5 mg/mL · Injection, Solution · Epidural; Infiltration; Perineural · Eugia US LLC

NDC 55150-0197-20 · 25 VIAL, SINGLE-DOSE in 1 CARTON / 20 mL in 1 VIAL, SINGLE-DOSE · ANDA · View full market →

The short version

15 companies supply this market — deep enough that no single failure threatens the supply. It is in shortage right now — FDA lists the reason as “other”. One of its named manufacturing plants, Eugia Pharma Specialities Limited, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Estimated fill cost

WAC per package, as filed
$140.00
Reported to Texas DSHS · 2026 annual filing · Eugia Us Llc

Manufacturer list price as filed — not what pharmacies actually pay after discounts.

Medicare Part B (ASP)

Payment limit per 1 MG
$0.039
HCPCS J2795 · Jul 1, 2026 quarter · typically ASP + 6%

Medicaid spend (2025)

$16,880
908 prescriptions paid by Medicaid nationally · all Medicaid spend →

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

Where it's made

Establishments this product's FDA label declares, located via FDA registration data. How we built this →

Is this a "specialty" drug?

There's no legal definition — it meets 1 of 6 public criteria. Why that matters →

  • Part D specialty tier
  • Costs ≥ $950/fill
  • Biologic (BLA)
  • Injectable / infused
  • Orphan-drug exclusivity
  • REMS program

Regulatory

Application
ANDA205612
TE code
AP
Approval date
Jul 13, 2016
Patents / exclusivity
None on file

Shortage history

  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-66)Mar 27, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-67)Mar 27, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-82)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 2 mg/1 mL (NDC 25021-671-87)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-82)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Ropivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 25021-652-87)Mar 27, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-10)Mar 23, 2018
    Delay in shipping of the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-11)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-20)Mar 23, 2018
    Delay in shipping of the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 10 mg/1 mL (NDC 63323-288-21)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-10)Mar 23, 2018
    Demand increase for the drug
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-13)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-20)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-23)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-61)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-63)Mar 23, 2018
    Other
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-64)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 63323-285-65)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-10)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months
  • In shortage now — Naropin, Injection, 2 mg/1 mL (NDC 65219-632-20)Mar 23, 2018
    month 102 — 5× the typical 20-month injectable shortage · model puts 24% odds it resolves within 6 months

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Ropivacaine Hydrochloride (Injection, Solution)

LabelerStrengthFirst seenLast seen
Baxter Healthcare CorporationROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Gland Pharma LimitedROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Glenmark Pharmaceuticals Inc., USAROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
Hikma Pharmaceuticals USA Inc.ROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 3, 2026
SOLA Pharmaceuticals, LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 3, 2026
Anthea Pharma Private LimitedROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Anthea Pharma Private LimitedROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Eugia US LLCROPIVACAINE HYDROCHLORIDE 7.5 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 7.5 mg/mLJul 15, 2026Sep 2, 2026
Fresenius Kabi Usa, LlcROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Sep 2, 2026
Glenmark Pharmaceuticals Inc., USAROPIVACAINE HYDROCHLORIDE 10 mg/mLJul 15, 2026Sep 2, 2026
Henry Schein, Inc.ROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Hikma Pharmaceuticals USA Inc.ROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Meitheal Pharmaceuticals Inc.ROPIVACAINE HYDROCHLORIDE 7.5 mg/mLJul 15, 2026Sep 2, 2026
Sagent PharmaceuticalsROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Sportpharm LLCROPIVACAINE HYDROCHLORIDE 5 mg/mLJul 15, 2026Sep 2, 2026
Mylan Institutional LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Sagent PharmaceuticalsROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 31, 2026
Excella GmbH & Co. KGROPIVACAINE HYDROCHLORIDE 1 kg/kgJul 15, 2026Aug 28, 2026
Fresenius Kabi USA, LLCROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 28, 2026
Glenmark Pharmaceuticals Inc., USAROPIVACAINE HYDROCHLORIDE 2 mg/mLJul 15, 2026Aug 28, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Ropivacaine Hydrochloride — NDC 55150-0197-20," retrieved September 3, 2026, https://drugdashboards.com/drug/55150019720.

Free to cite with attribution — see how the data is put together.